HSBC Holdings’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

HSBC Holdings’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-456,623	Closed	-$8.48M	–	2985
2023 Q3	$8.48M	Buy	+456,623	New	+$5.17M	0.01%	885
2019 Q4	–	Sell	-21,678	Closed	-$1.44M	–	3231
2019 Q3	$1.44M	Buy	+21,678	New	+$1.46M	﹤0.01%	1768
2018 Q4	–	Sell	-5,915	Closed	-$748K	–	2757
2018 Q3	$748K	Buy	+5,915	New	+$626K	﹤0.01%	1862
2018 Q1	–	Sell	-415	Closed	-$24K	–	2612
2017 Q4	$24K	Buy	415 +156	+60%	+$9.84K	﹤0.01%	2008
2017 Q3	$15K	Buy	+259	New	+$27.9K	﹤0.01%	2279
2015 Q3	–	Sell	-1,336	Closed	-$322K	–	2212
2015 Q2	$322K	Sell	1,336 -516	-28%	-$137K	﹤0.01%	1578
2015 Q1	$522K	Buy	+1,852	New	+$401K	﹤0.01%	1543

HSBC Holdings's ICPT Position: Q4 2023 in Review

HSBC Holdings sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 456,623 shares — an estimated $8.48M sold.

HSBC Holdings first reported a position in ICPT in Q1 2015 and held it in 7 quarters. The position peaked at $8.48M in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

HSBC Holdings reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
HSBC Holdings sold 456,623 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $8.48M.
HSBC Holdings first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2015 and held it in 7 quarters.
HSBC Holdings's Intercept Pharmaceuticals, Inc. position peaked at $8.48M in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on HSBC Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.